• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物诱发的银屑病:是药物诱导还是药物加重?:了解病理生理学和临床相关性。

Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.

作者信息

Kim Grace K, Del Rosso James Q

出版信息

J Clin Aesthet Dermatol. 2010 Jan;3(1):32-8.

PMID:20725536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2921739/
Abstract

Psoriasis is a commonly encountered dermatosis with a variety of internal and external paradoxical factors contributing to the clinical course of the disease. There are several drugs described in the literature that have been associated with the initiation, exacerbation, and aggravation of psoriasis. Understanding the pathophysiology can provide clues to treatment and management of drug-induced and drug-aggravated psoriasis, which may be indistinguishable from idiopathic psoriasis. The clinical manifestations of drug-associated psoriasis can range from plaque-type psoriasis to severe erythroderma, thus warranting astute and sustained clinical observation.

摘要

银屑病是一种常见的皮肤病,多种内在和外在的矛盾因素影响着该疾病的临床病程。文献中描述了几种与银屑病的发生、加重及恶化相关的药物。了解其病理生理学可为药物性银屑病和药物加重性银屑病的治疗与管理提供线索,这两种情况可能与特发性银屑病难以区分。药物相关性银屑病的临床表现范围从斑块型银屑病到严重的红皮病,因此需要敏锐且持续的临床观察。

相似文献

1
Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.药物诱发的银屑病:是药物诱导还是药物加重?:了解病理生理学和临床相关性。
J Clin Aesthet Dermatol. 2010 Jan;3(1):32-8.
2
Drug-induced psoriasis. Recognition and management.药物性银屑病。识别与管理。
Am J Clin Dermatol. 2000 May-Jun;1(3):159-65. doi: 10.2165/00128071-200001030-00003.
3
The role of drugs in the induction and/or exacerbation of psoriasis.药物在诱导和/或加重银屑病中的作用。
Int J Dermatol. 2010 Dec;49(12):1351-61. doi: 10.1111/j.1365-4632.2010.04570.x.
4
Clinical analysis of 84 cases of erythrodermic psoriasis and 121 cases of other types of erythroderma from 2010-2015.2010年至2015年84例红皮病型银屑病及121例其他类型红皮病的临床分析。
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):563-567. doi: 10.1007/s11596-017-1773-1. Epub 2017 Aug 8.
5
Psoriasis induced or aggravated by drugs.药物诱发或加重的银屑病。
J Rheumatol Suppl. 2009 Aug;83:59-61. doi: 10.3899/jrheum.090227.
6
Repeated Paradoxical Aggravation of Preexisting Psoriasis during Infliximab Treatment for Crohn's Disease.英夫利昔单抗治疗克罗恩病期间原有银屑病反复出现矛盾性加重
Ann Dermatol. 2009 Feb;21(1):60-2. doi: 10.5021/ad.2009.21.1.60. Epub 2009 Feb 28.
7
Infection-provoked psoriasis: Induced or aggravated (Review).感染诱发的银屑病:诱发或加重(综述)
Exp Ther Med. 2021 Jun;21(6):567. doi: 10.3892/etm.2021.9999. Epub 2021 Mar 29.
8
Paradoxical Psoriasis Induced by Ustekinumab: A Comprehensive Review and Case Report.乌司奴单抗诱导的矛盾性银屑病:全面综述及病例报告。
Medicina (Kaunas). 2024 Jan 6;60(1):106. doi: 10.3390/medicina60010106.
9
Exacerbation of Psoriasis Following COVID-19 Vaccination: Report From a Single Center.新型冠状病毒肺炎疫苗接种后银屑病病情加重:来自单一中心的报告
Front Med (Lausanne). 2021 Dec 23;8:812010. doi: 10.3389/fmed.2021.812010. eCollection 2021.
10
Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapy.肿瘤坏死因子α拮抗剂治疗期间皮肤银屑病的发作或加重。
Joint Bone Spine. 2008 May;75(3):315-8. doi: 10.1016/j.jbspin.2007.06.011. Epub 2008 Feb 11.

引用本文的文献

1
Barium and psoriasis: a mini-review and hypothesis linking environmental exposures to ion channel modulation.钡与银屑病:一篇关于环境暴露与离子通道调节之间联系的小型综述及假说
Front Med (Lausanne). 2025 Jun 18;12:1585525. doi: 10.3389/fmed.2025.1585525. eCollection 2025.
2
Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches.通过整合分子对接、单支持向量机算法和分子动力学模拟方法,将美国食品药品监督管理局(FDA)批准的药物用于银屑病适应症的重新利用。
Sci Rep. 2025 Jul 1;15(1):21211. doi: 10.1038/s41598-025-01448-7.
3
The treatment of psoriasis via herbal formulation and nano-polyherbal formulation: A new approach.通过草药配方和纳米多草药配方治疗银屑病:一种新方法。
Bioimpacts. 2024 Aug 11;15:30341. doi: 10.34172/bi.30341. eCollection 2025.
4
Pharmacotherapy of arterial hypertension in patients with psoriasis.银屑病患者动脉高血压的药物治疗
J Hypertens. 2025 Apr 1;43(4):568-576. doi: 10.1097/HJH.0000000000003982. Epub 2025 Feb 17.
5
A case of probable drug-induced psoriasis to dapagliflozin.一例可能由达格列净引起的药物性银屑病病例。
SAGE Open Med Case Rep. 2024 Nov 28;12:2050313X241284003. doi: 10.1177/2050313X241284003. eCollection 2024.
6
Bedaquiline-induced psoriasiform drug eruption in a patient of multidrug-resistant tuberculosis.一名耐多药结核病患者出现的贝达喹啉诱发的银屑病样药疹。
Indian J Pharmacol. 2024 May 1;56(3):228-230. doi: 10.4103/ijp.ijp_49_24. Epub 2024 Jul 5.
7
Ruptured abdominal aortic aneurysm in psoriasis: A case report and review of literature.银屑病患者腹主动脉瘤破裂:一例报告并文献复习
Int J Surg Case Rep. 2024 Jul;120:109829. doi: 10.1016/j.ijscr.2024.109829. Epub 2024 May 29.
8
Topical Management of Plaque Psoriasis-A Review and Case Series Discussion with Focus on Aryl Hydrocarbon Receptor Modulation.斑块状银屑病的局部治疗——聚焦芳烃受体调节的综述及病例系列讨论
J Clin Aesthet Dermatol. 2023 Sep;16(9 Suppl 1):S3-S12.
9
Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.罕见并发症 - 皮肤萎缩 - 婴儿血管瘤系统保守治疗后。
BMC Pediatr. 2024 Feb 23;24(1):138. doi: 10.1186/s12887-024-04638-w.
10
The Causal Association Between Medication Intake and Increased Risk of Psoriasis.药物摄入与银屑病风险增加之间的因果关联。
Dermatol Pract Concept. 2024 Jan 1;14(1):e2024041. doi: 10.5826/dpc.1401a41.

本文引用的文献

1
Development of a psoriasis-like syndrome following lithium therapy.锂治疗后出现银屑病样综合征。
Biol Trace Elem Res. 1987 Dec;14(3):169-77. doi: 10.1007/BF02795684.
2
Exacerbation of psoriasis with beta-blocker therapy.β受体阻滞剂治疗引发银屑病病情加重。
CMAJ. 2009 Jul 7;181(1-2):60. doi: 10.1503/cmaj.081433.
3
Lithium and psoriasis: what primary care and family physicians should know.锂与银屑病:基层医疗和家庭医生应了解的知识。
Prim Care Companion J Clin Psychiatry. 2008;10(6):435-9. doi: 10.4088/pcc.v10n0602.
4
Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study.β受体阻滞剂、其他降压药物与银屑病之间的关联:基于人群的病例对照研究。
Br J Dermatol. 2008 Jun;158(6):1299-307. doi: 10.1111/j.1365-2133.2008.08563.x. Epub 2008 Apr 10.
5
Psoriasiform dermatoses.银屑病样皮肤病
Indian J Dermatol Venereol Leprol. 2008 Mar-Apr;74(2):94-9. doi: 10.4103/0378-6323.39688.
6
Onset or exacerbation of cutaneous psoriasis during TNFalpha antagonist therapy.肿瘤坏死因子α拮抗剂治疗期间皮肤银屑病的发作或加重。
Joint Bone Spine. 2008 May;75(3):315-8. doi: 10.1016/j.jbspin.2007.06.011. Epub 2008 Feb 11.
7
Triggering psoriasis: the role of infections and medications.引发银屑病:感染与药物的作用
Clin Dermatol. 2007 Nov-Dec;25(6):606-15. doi: 10.1016/j.clindermatol.2007.08.015.
8
Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-alpha inhibition.一名自杀倾向患者中难治性锂诱导的银屑病通过肿瘤坏死因子-α抑制得到缓解。
Br J Dermatol. 2007 Sep;157(3):627-9. doi: 10.1111/j.1365-2133.2007.08052.x. Epub 2007 Jun 26.
9
Association between the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in Taiwan.台湾华裔人群中血管紧张素I转换酶基因插入/缺失多态性与银屑病风险的关联。
Br J Dermatol. 2007 Apr;156(4):642-5. doi: 10.1111/j.1365-2133.2006.07716.x. Epub 2007 Jan 30.
10
The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis.锂盐和β受体阻滞剂诱发及加重银屑病的机制。
J Drugs Dermatol. 2006 May;5(5):426-32.